Studies in transgenic mouse models of AD suggest that multiple, overlapping processes might contribute to abnormal hyperphosphorylation of tau, including Aβ, impaired brain glucose metabolism, and inflammation [63,64,65]. The gene discussed is MAPT; the disease is Alzheimer disease.